Performant Q1 healthcare rev up 13% to $25.8M; net loss narrows to $4.0M; reaffirms FY24 guidance

Performant Healthcare Inc

2024-Q1 EPS reported -$0.05 revenue$27,334,000

Healthcare revenue $25.8M (+13% YoY); total revenue $27.3M (+6% YoY).
Net loss of $4.0M ($0.05/sh) vs $4.2M ($0.06/sh) prior year; adjusted net loss $3.0M.
Adj. EBITDA improved to $(1.2)M from $(1.7)M prior year.
Reaffirmed FY2024 guidance: healthcare rev $117-122M, total rev $124-129M, adj EBITDA $4-5M.
Acquired AI technology from RecordsOne in April; 10 commercial programs implemented in Q1.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Performant Healthcare Inc reported first quarter ended March 31, 2024 results: revenue $27.3 million, net income $(0.05) per diluted share. Guidance reaffirmed.

Period: first quarter ended March 31, 2024
Revenue: $27.3 million
Net income: $(0.05) per diluted share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Quarter Financial Highlights • Healthcare revenues of $25.8 million, compared to $22.9 million in the prior year period, an increase of approximately 13%. • Total revenues of $27.3 million, compared to total revenues of $25.7 million in the prior year period. • Net loss of $4.0 million, or $(0.05) per diluted share, compared to net loss of $4.2 million, or $(0.06)

View on SEC.gov

708 earnings releases filed in the last 30 days. Browse all earnings releases →

Source: SEC EDGAR

accession 0001550695-24-000040

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.